Identification of oxidative degradation impurities of olanzapine drug substance as well as drug product

J Pharm Biomed Anal. 2011 Sep 10;56(2):413-8. doi: 10.1016/j.jpba.2011.05.003. Epub 2011 May 12.

Abstract

Impurities found in stressed and stability studies of olanzapine (polymorphic form-I) [1-7] in both drug substance and drug product are described. These impurities are identified as 4-(4-methyl-1-piperazinyl)-3-hydroxymethylidene-1H-benzo[b][1,4]diazepine-2(3H)-thione (hydroxymethylidene thione) and (Z)-4-(4-methyl-1-piperazinyl)-3-acetoxymethylidene-1H-benzo[b][1,4]diazapine-2(3H)-thione (acetoxymethylidene thione). An oxidative degradation pathway of olanzapine, for the formation of these impurities, has been proposed.

MeSH terms

  • Antipsychotic Agents / analysis*
  • Antipsychotic Agents / chemistry
  • Benzodiazepines / analysis*
  • Benzodiazepines / chemistry
  • Chemistry, Pharmaceutical
  • Chromatography, High Pressure Liquid
  • Drug Contamination*
  • Drug Stability
  • Excipients / analysis
  • Magnetic Resonance Spectroscopy
  • Molecular Structure
  • Olanzapine
  • Oxidation-Reduction
  • Tablets
  • Tandem Mass Spectrometry
  • Technology, Pharmaceutical / methods

Substances

  • Antipsychotic Agents
  • Excipients
  • Tablets
  • Benzodiazepines
  • Olanzapine